According to Standard BioTools's latest financial reports the company's current EPS (TTM) is S-$0.45. In 2024 the company made an earnings per share (EPS) of S-$0.71 an increase over its 2023 EPS that were of S-$1.22.
Year | EPS | Change |
---|---|---|
2025 (TTM) | S-$0.47 | -33.79% |
2024 | S-$0.71 | -42.11% |
2023 | S-$1.22 | -61.07% |
2022 | S-$3.14 | 212.82% |
2021 | S-$1.00 | 6.85% |
2020 | S-$0.94 | -27.72% |
2019 | S-$1.30 | -32.67% |
2018 | S-$1.93 | -21.05% |
2017 | S-$2.45 | -27.48% |
2016 | S-$3.37 | 40.86% |
2015 | S-$2.39 | -2.11% |
2014 | S-$2.45 | 206.45% |
2013 | S-$0.80 | -28.74% |
2012 | S-$1.12 |